Spotlight
Video

Combination therapies in CLL: ibrutinib and venetoclax

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: There has been a multitude of novel, exciting therapies within the field of chronic lymphocytic leukemia (CLL), explains Stephen Devereux, FRCP, FRCPath, PhD, of King’s College Hospital NHS Foundation Trust, London, UK. At the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, in Liverpool, UK, Prof. Devereux discusses the CLARITY trial (ISCRTN13751862), exploring a combination of ibrutinib and venetoclax, and the promise that this may in the future result in a curative therapy for certain patients.
Shared By : VJHemOnc
Posted on : 07/20/18
Added : 12 months ago